Structural equation modeling of the proximal-distal continuum of adherence drivers

Patient Preference and Adherence

Volumn 6, Issue , 2012, Pages 789-804

  McHorney, Colleen A ^a   Zhang, Ning Jackie ^b   Stump, Timothy ^c   Zhao, Xiaoquan ^d  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF CENTRAL FLORIDA   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GEORGE MASON UNIVERSITY   (United States)

Author keywords

Compliance; Medication beliefs; Prescription medications; Treatment beliefs

Indexed keywords

HERBACEOUS AGENT; MINERAL; NUTRACEUTICAL; VITAMIN;

ADULT; ADVERSE DRUG REACTION; AGE DISTRIBUTION; AGED; ARTICLE; ASTHMA; CAUCASIAN; CONCEPTUAL FRAMEWORK; DIABETES MELLITUS; DISEASE SEVERITY; DOCTOR PATIENT RELATION; DRUG COST; EDUCATION; ETHNIC DIFFERENCE; FEMALE; HEALTH BELIEF; HEALTH SURVEY; HISPANIC; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNITY; INCOME; INFORMATION SEEKING; KNOWLEDGE; LOCUS OF CONTROL; MALE; MEDICAL INFORMATION; MENTAL HEALTH; NEGRO; OSTEOPOROSIS; PATIENT ATTITUDE; PATIENT CARE; PATIENT EDUCATION; PREDICTION; PRESCRIPTION; PROXIMAL DISTAL CONTINUUM OF ADHERENCE DRIVERS; SELF CONCEPT; SEX DIFFERENCE; SIDE EFFECT IMMUNITY; STRUCTURAL EQUATION MODELING;

EID: 84882974018     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S36535     Document Type: Article

References (190)

1. Brawley LR, Culos-Reed SN. Studying adherence to therapeutic regimens: overview, theories, recommendations. Control Clin Trials. 2000;21(Suppl 5):S156-S163.
2. Becker MH, Maiman LA. Sociobehavioral determinants of compliance with health and medical care recommendations. Med Care. 1975;13(1):10-24.
3. Fumaz CR, Muñoz-Moreno JA, Moltó J, et al. Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: attitudes and beliefs. AIDS Care. 2008;20(7):796-805.
4. Farmer A, Kinmonth AL, Sutton S. Measuring beliefs about taking hypoglycaemic medication among people with Type 2 diabetes. Diabet Med. 2006;23(3):265-270.
5. Johnson SS, Driskell MM, Johnson JL, et al. Transtheoretical model intervention for adherence to lipid-lowering drugs. Dis Manag. 2006;9(2):102-114.
6. Horne R. Representations of medications and treatment: advances in theory and measurement. In: Petrie KJ, Weinman JA, editors. Perceptions of Health and Illness. Amsterdam: Harwood; 1997:155-188.
7. Amico KR, Toro-Alfonso J, Fisher JD. An empirical test of the information, motivation and behavioral skills model of antiretroviral therapy adherence. AIDS Care. 2005;17(6):661-673.
8. DiMatteo MR, Haskard-Zolnierek KB, Martin LR. Improving patient adherence: a three-factor model to guide practice. Health Psychol Rev. 2012;6(1):74-91.
9. McHorney CA. The Adherence Estimator: a brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease. Curr Med Res Opin. 2009;25(1):215-238.
10. Gardner EM, Burman WJ, Maravi ME, Davidson AJ. Selective drug taking during combination antiretroviral therapy in an unselected clinic population. J Acquir Immune Defic Syndr. 2005;40(3):294-300.
11. Ho PM, Spertus JA, Masoudi FA, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med. 2006;166(17):1842-1847.
12. Lo Re V 3rd, Teal V, Localio AR, Amorosa VK, Kaplan DE, Gross R. Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study. Ann Intern Med. 2011;155(6):353-360.
13. Krigsman K, Nilsson JL, Ring L. Adherence to multiple drug therapies: refill adherence to concomitant use of diabetes and asthma/COPD medication. Pharmacoepidemiol Drug Saf. 2007;16(10):1120-1128.
14. Piette JD, Heisler M, Ganoczy D, McCarthy JF, Valenstein M. Differential medication adherence among patients with schizophrenia and comorbid diabetes and hypertension. Psychiatr Serv. 2007;58(2):207-212.
15. Agarwal S, Tang SS, Rosenberg N, et al. Does synchronizing initiation of therapy affect adherence to concomitant use of antihypertensive and lipid-lowering therapy? Am J Ther. 2009;16(2):119-126.
16. Benner JS, Chapman RH, Petrilla AA, Tang SS, Rosenberg N, Schwartz JS. Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy. Am J Health Syst Pharm. 2009;66(16):1471-1477.
17. Yood RA, Mazor KM, Andrade SE, Emani S, Chan W, Kahler KH. Patient decision to initiate therapy for osteoporosis: the influence of knowledge and beliefs. J Gen Intern Med. 2008;23(11):1815-1821.
18. Horne R, Weinman J. Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health. 2002;17(1):17-32.
19. Nicklas LB, Dunbar M, Wild M. Adherence to pharmacological treatment of non-malignant chronic pain: the role of illness perceptions and medication beliefs. Psychol Health. 2010;25(5):1-15.
20. Schousboe JT, Davison ML, Dowd B, Thiede Call K, Johnson P, Kane RL. Predictors of patients' perceived need for medication to prevent fracture. Med Care. 2011;49(3):273-280.
21. Baloush-Kleinman V, Levine SZ, Roe D, Shnitt D, Weizman A, Poyurovsky M. Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study. Schizophr Res. 2011;130(1-3):176-181.
22. Ackerson K, Preston SD. A decision theory perspective on why women do or do not decide to have cancer screening: systematic review. J Adv Nurs. 2009;65(6):1130-1140.
23. Oggins J. Notions of HIV and medication among multiethnic people living with HIV. Health Soc Work. 2003;28(1):53-62.
24. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200-209.
25. Treharne GJ, Lyons AC, Kitas GD. Medication adherence in rheumatoid arthritis: effects of psychosocial factors. Psychol Health Med. 2004;9(3):337-349.
26. Byrne M, Walsh J, Murphy AW. Secondary prevention of coronary heart disease: patient beliefs and health-related behaviour. J Psychosom Res. 2005;58(5):403-415.
27. Grunfeld EA, Hunter MS, Sikka P, Mittal S. Adherence beliefs among breast cancer patients taking tamoxifen. Patient Educ Couns. 2005;59(1):97-102.
28. Sud A, Kline-Rogers EM, Eagle KA, et al. Adherence to medications by patients after acute coronary syndromes. Ann Pharmacother. 2005;39(11):1792-1797.
29. Horne R, Cooper V, Gellaitry G, Date HL, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: the utility of the necessity-concerns framework. J Acquir Immune Defic Syndr. 2007;45(3):334-341.
30. Gonzalez JS, Penedo FJ, Llabre MM, et al. Physical symptoms, beliefs about medications, negative mood, and long-term HIV medication adherence. Ann Behav Med. 2007;34(1):46-55.
31. Moshkovska T, Stone MA, Clatworthy J, et al. An investigation of medication adherence to 5-aminosalicylic acid therapy in patients with ulcerative colitis, using self-report and urinary drug excretion measurements. Aliment Pharmacol Ther. 2009;30(11-12):1118-1127.
32. Bucks RS, Hawkins K, Skinner TC, Horn S, Seddon P, Horne R. Adherence to treatment in adolescents with cystic fibrosis: the role of illness perceptions and treatment beliefs. J Pediatr Psychol. 2009; 34(8):893-902.
33. Clatworthy J, Bowskill R, Parham R, Rank T, Scott J, Horne R. Understanding medication non-adherence in bipolar disorders using a Necessity-Concerns Framework. J Affect Disord. 2009;116(1-2):51-55.
34. Schousboe JT, Dowd BE, Davison ML, Kane RL. Association of medication attitudes with non-persistence and non-compliance with medication to prevent fractures. Osteoporos Int. 2010;21(11):1899-1909.
35. Griva K, Davenport A, Harrison M, Newman SP. Non-adherence to immunosupressive medications in kidney transplantation: intent vs forgetfulness and clinical markers of medication intake. Ann Behav Med. 2012;44(1):85-93.
36. Ruppar TM, Dobbels F, De Geest S. Medication beliefs and antihypertensive adherence among older adults: a pilot study. Geriatr Nurs. 2012;33(2):89-95.
37. Schoenthaler AM, Schwartz BS, Wood C, Stewart WF. Patient and physician factors associated with adherence to diabetes medications. Diabetes Educ. 2012;38(3):397-408.
38. Maidment R, Livingston G, Katona C. Just keep taking the tablets: adherence to antidepressant treatment in older people in primary care. Int J Geriatr Psychiatry. 2002;17(8):752-757.
39. Ayalon L, Areán PA, Alvidrez J. Adherence to antidepressant medications in black and Latino elderly patients. Am J Geriatr Psychiatry. 2005;13(7):572-580.
40. Gellaitry G, Cooper V, Davis C, Fisher M, Date HL, Horne R. Patients' perception of information about HAART: impact on treatment decisions. AIDS Care. 2005;17(3):367-376.
41. Carr AJ, Thompson PW, Cooper C. Factors associated with adherence and persistence to bisphosphonate therapy in osteoporosis: a cross-sectional survey. Osteoporos Int. 2006;17(11):1638-1644.
42. Hunot VM, Horne R, Leese MN, Churchill RC. A cohort study of adherence to antidepressants in primary care: the influence of antidepressant concerns and treatment preferences. Prim Care Companion J Clin Psychiatry. 2007;9(2):91-99.
43. Mann DM, Allegrante JP, Natarajan S, Halm EA, Charlson M. Predictors of adherence to statins for primary prevention. Cardiovasc Drugs Ther. 2007;21(4):311-316.
44. Aikens JE, Piette JD. Diabetic patients' medication underuse, illness outcomes, and beliefs about antihyperglycemic and antihypertensive treatments. Diabetes Care. 2009;32(1):19-24.
45. Daleboudt GM, Broadbent E, McQueen F, Kaptein AA. Intentional and unintentional treatment nonadherence in patients with systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2011;63(3):342-350.
46. O'Carroll R, Whittaker J, Hamilton B, Johnston M, Sudlow C, Dennis M. Predictors of adherence to secondary preventive medication in stroke patients. Ann Behav Med. 2011;41(3):383-390.
47. Solomon DH, Brookhart MA, Tsao P, et al. Predictors of very low adherence with medications for osteoporosis: towards development of a clinical prediction rule. Osteoporos Int. 2011;22(6):1737-1743.
48. Patel SC, Spaeth GL. Compliance in patients prescribed eyedrops for glaucoma. Ophthalmic Surg. 1995;26(3):233-236.
49. Brown CM, Segal R. The effects of health and treatment perceptions on the use of prescribed medication and home remedies among African American and white American hypertensives. Soc Sci Med. 1996;43(6):903-917.
50. Goeman DP, Aroni RA, Stewart K, et al. Patients' views of the burden of asthma: a qualitative study. Med J Aust. 2002;177(6):295-299.
51. Kamatari M, Koto S, Ozawa N, et al. Factors affecting long-term compliance of osteoporotic patients with bisphosphonate treatment and QOL assessment in actual practice: alendronate and risedronate. J Bone Miner Metab. 2007;25(5):302-309.
52. Friedman DS, Hahn SR, Gelb L, et al. Doctor-patient communication, health-related beliefs, and adherence in glaucoma: results from the Glaucoma Adherence and Persistency Study. Ophthalmology. 2008;115(8):1320-1327.
53. Wu JR, Moser DK, Chung ML, Lennie TA. Predictors of medication adherence using a multidimensional adherence model in patients with heart failure. J Card Fail. 2008;14(7):603-614.
54. Kim E, Gupta S, Bolge S, Chen CC, Whitehead R, Bates JA. Adherence and outcomes associated with copayment burden in schizophrenia: a cross-sectional survey. J Med Econ. 2010;13(2):185-192.
55. Marshall IJ, Wolfe CD, Mckevitt C. Lay perspectives on hypertension and drug adherence: systematic review of qualitative research. BMJ. 2012;345:e3953.
56. National Center for Health Statistics. Health, United States, 2010: With Special Feature on Death and Dying. Hyattsville: US Department of Health and Human Services; 2011.
57. DeVol R, Bedroussian A, Charuworn A, et al. An Unhealthy America: The Economic Burden of Chronic Disease-Charting a New Course to Save Lives and Increase Productivity and Economic Growth. Santa Monica: The Milken Institute; 2007.
58. The American Association for Public Opinion Research. Standard Definitions: Final Dispositions of Case Codes and Outcome Rates for Surveys. Lenexa: AAPOR; 2008.
59. Wallston KA. Multidimensional health locus of control (MHLC) scales [updated June 15, 2007]. Available from: http://www.vanderbilt.edu/nursing/kwallston/mhlcscales.htm. Accessed January 15, 2008.
60. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30(6):473-483.
61. McHorney CA, Gadkari AS. Individual patients hold different beliefs to prescription medications to which they persist vs nonpersist and persist vs nonfulfill. Patient Prefer Adherence. 2010;4:187-195.
62. McHorney CA, Spain CV. Frequency of and reasons for medication non-fulfillment and non-persistence among American adults with chronic disease in 2008. Health Expect. 2011;14(3):307-320.
63. Piette JD, Beard A, Rosland AM, McHorney CA. Beliefs that influence cost-related medication non-adherence among the "haves" and "have nots" with chronic diseases. Patient Prefer Adherence. 2011;5:389-396.
64. Gadkari AS, McHorney CA. Unintentional non-adherence to chronic prescription medications: how unintentional is it really? BMC Health Serv Res. 2012. Epub June 14.
65. Likert R. A technique for the measurement of attitudes. Arch Psychol. 1932;140:5-55.
66. Wright S. Correlation and causation. J Agric Res. 1921;20:557-585.
67. Wright S. The method of path coefficients. Ann Math Stat. 1934;5:161-215.
68. Wright S. Path coefficients and path regressions: alternative or complementary concepts. Biometrics. 1960;16:189-202.
69. Bollen KA. Structural Equations with Latent Variables, New York: Wiley & Sons; 1989.
70. Muthün L, Müthen B. Mplus User's Guide. 6th ed. Los Angeles: Muthen & Muthen; 1998-2007.
71. Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Structural Equation Modeling. 1999;6:1-55.
72. Kline R. Principles and Practice of Structural Equation Modeling. 3rd ed. New York: Guilford; 2010.
73. Bentler PM, Bonett DG. Significance tests and goodness of fit in the analysis of covariance structures. Psychol Bulletin. 1980;88:588-606.
74. Jöreskog K, Sörbom D. LISREL 8: User's Reference Guide. Chicago: Scientific Software Int; 1996.
75. McIntosh C. Rethinking fit assessment in structural equation modelling: A commentary and elaboration on Barrett. Pers Individ Dif. 2007;42:859-867.
76. Aikens JE, Nease DE Jr, Klinkman MS. Explaining patients' beliefs about the necessity and harmfulness of antidepressants. Ann Fam Med. 2008;6(1):23-29.
77. Horne R, Parham R, Driscoll R, Robinson A. Patients' attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease. Inflamm Bowel Dis. 2009;15(6):837-844.
78. Sirey JA, Bruce ML, Alexopoulos GS, Perlick DA, Friedman SJ, Meyers BS. Stigma as a barrier to recovery: Perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatr Serv. 2001;52(12):1615-1620.
79. De Smet BD, Erickson SR, Kirking DM. Self-reported adherence in patients with asthma. Ann Pharmacother. 2006;40(3):414-420.
80. Bardel A, Wallander MA, Svärdsudd K. Factors associated with adherence to drug therapy: a population-based study. Eur J Clin Pharmacol. 2007;63(3):307-314.
81. Bolman C, Arwert TG, Völlink T. Adherence to prophylactic asthma medication: habit strength and cognitions. Heart Lung. 2011;40(1):63-75.
82. Unni E, Farris KB. Determinants of different types of medication non-adherence in cholesterol lowering and asthma maintenance medications: a theoretical approach. Patient Educ Couns. 2011;83(3):382-390.
83. DiMatteo MR, Haskard KB, Williams SL. Health beliefs, disease severity, and patient adherence: a meta-analysis. Med Care. 2007;45(6):521-528.
84. Viller F, Guillemin F, Briancon S, Moum T, Suurmeijer T, van den Heuvel W. Compliance to drug treatment of patients with rheumatoid arthritis: a 3 year longitudinal study. J Rheumatol. 1999;26(10):2114-2122.
85. Kim EY, Han HR, Jeong S, et al. Does knowledge matter? Intentional medication nonadherence among middle-aged Korean Americans with high blood pressure. J Cardiovasc Nurs. 2007;22(5):397-404.
86. Ringe JD, Christodoulakos GE, Mellström D, et al. Patient compliance with alendronate, risedronate and raloxifene for the treatment of osteoporosis in postmenopausal women. Curr Med Res Opin. 2007;23(11):2677-2687.
87. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348-354.
88. Wells K, Pladevall M, Peterson EL, et al. Race-ethnic differences in factors associated with inhaled steroid adherence among adults with asthma. Am J Respir Crit Care Med. 2008;178(12):1194-1201.
89. Bermejo F, López-San Román A, Algaba A, et al. Factors that modify therapy adherence in patients with inflammatory bowel disease. J Crohns Colitis. 2010;4(4):422-426.
90. Son YJ, Kim HG, Kim EH, Choi S, Lee SK. Application of support vector machine for prediction of medication adherence in heart failure patients. Healthc Inform Res. 2010;16(4):253-259.
91. Al-Qazaz HK, Sulaiman SA, Hassali MA, et al. Diabetes knowledge, medication adherence and glycemic control among patients with type 2 diabetes. Int J Clin Pharm. 2011;33(6):1028-1035.
92. Bowry AD, Shrank WH, Lee JL, Stedman M, Choudhry NK. A systematic review of adherence to cardiovascular medications in resource-limited settings. J Gen Intern Med. 2011;26(12):1479-1491.
93. Parashos IA, Xiromeritis K, Zoumbou V, Stamouli S, Theodotou R. The problem of non-compliance in schizophrenia: opinions of patients and their relatives. A pilot study. Int J Psychiatry Clin Pract. 2000;4(2):147-150.
94. Mansur AP, Mattar AP, Tsubo CE, Simão DT, Yoshi FR, Daci K. Prescription and adherence to statins of patients with coronary artery disease and hypercholesterolemia. Arq Bras Cardiol. 2001;76(2):111-118.
95. Kripalani S, Henderson LE, Jacobson TA, Vaccarino V. Medication use among inner-city patients after hospital discharge: patient-reported barriers and solutions. Mayo Clin Proc. 2008;83(5):529-535.
96. Sajatovic M, Levin J, Fuentes-Casiano E, Cassidy KA, Tatsuoka C, Jenkins JH. Illness experience and reasons for nonadherence among individuals with bipolar disorder who are poorly adherent with medication. Compr Psychiatry. 2011;52(3):280-287.
97. Tolmie EP, Lindsay GM, Kerr SM, Brown MR, Ford I, Gaw A. Patients' perspectives on statin therapy for treatment of hypercholesterolaemia: a qualitative study. Eur J Cardiovasc Nurs. 2003;2(2):141-149.
98. Bajramovic J, Emmerton L, Tett SE. Perceptions around concordance-focus groups and semi-structured interviews conducted with consumers, pharmacists and general practitioners. Health Expect. 2004;7(3):221-234.
99. Bollini P, Tibaldi G, Testa C, Munizza C. Understanding treatment adherence in affective disorders: a qualitative study. J Psychiatr Ment Health Nurs. 2004;11(6):668-674.
100. Gascón JJ, Sánchez-Ortuño M, Llor B, Skidmore D, Saturno PJ; for Treatment Compliance in Hypertension Study Group. Why hypertensive patients do not comply with the treatment: results from a qualitative study. Fam Pract. 2004;21(2):125-130.
101. Morecroft C, Cantrill J, Tully MP. Patients' evaluation of the appropriateness of their hypertension management-a qualitative study. Res Social Adm Pharm. 2006;2(2):186-211.
102. Barber N, Parsons J, Clifford S, Darracott R, Horne R. Patients' problems with new medication for chronic conditions. Qual Saf Health Care. 2004;13(3):172-175.
103. Neame R, Hammond A, Deighton C. Need for information and for involvement in decision making among patients with rheumatoid arthritis: a questionnaire survey. Arthritis Rheum. 2005;53(2):249-255.
104. Mochari H, Ferris A, Adigopula S, Henry G, Mosca L. Cardiovascular disease knowledge, medication adherence, and barriers to preventive action in a minority population. Prev Cardiol. 2007;10(4):190-195.
105. Shiri C, Srinivas SC, Futter WT, Radloff SE. The role of insight into and beliefs about medicines of hypertensive patients. Cardiovasc J Afr. 2007;18(6):353-357.
106. Hobbs FD, Erhardt LR, Rycroft C; for From the Heart study Investigators. The From The Heart study: a global survey of patient understanding of cholesterol management and cardiovascular risk, and physician-patient communication. Curr Med Res Opin. 2008;24(5):1267-1278.
107. Ridout S, Waters WE, George CF. Knowledge of and attitudes to medicines in the Southampton community. Br J Clin Pharmacol. 1986;21(6):701-712.
108. Enlund H, Vainio K, Wallenius S, Poston JW. Adverse drug effects and the need for drug information. Med Care. 1991;29(6):558-564.
109. McCormack PM, Lawlor R, Donegan C, et al. Knowledge and attitudes to prescribed drugs in young and elderly patients. Ir Med J. 1997;90(1):29-30.
110. Morris LA, Tabak ER, Gondek K. Counseling patients about prescribed medication: 12-year trends. Med Care. 1997;35(10):996-1007.
111. Barat I, Andreasen F, Damsgaard EM. Drug therapy in the elderly: what doctors believe and patients actually do. Br J Clin Pharmacol. 2001;51(6):615-622.
112. Sleath B, Wurst K. Patient receipt of, and preferences for receiving, antidepressant information. Int J Pharm Pract. 2002;10(4):235-241.
113. Coulter A. What do patients and the public want from primary care? BMJ. 2005;331(7526):1199-1201.
114. Gray R, Rofail D, Allen J, Newey T. A survey of patient satisfaction with and subjective experiences of treatment with antipsychotic medication. J Adv Nurs. 2005;52(1):31-37.
115. Paton C, Esop R. Patients' perceptions of their involvement in decision making about antipsychotic drug choice as outlined in the NICE guidance on the use of atypical antipsychotics in schizophrenia. J Ment Health. 2005;14(3):305-310.
116. Richard C, Lussier MT. Nature and frequency of exchanges on medications during primary care encounters. Patient Educ Couns. 2006;64(1-3):207-216.
117. Han PK, Kobrin SC, Klein WM, Davis WW, Stefanek M, Taplin SH. Perceived ambiguity about screening mammography recommendations: association with future mammography uptake and perceptions. Cancer Epidemiol Biomarkers Prev. 2007;16(3):458-466.
118. Peterson AM, Takiya L, Finley R. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm. 2003;60(7):657-665.
119. Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86(4):304-314.
120. Wilson SR, Strub P, Buist AS, et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. Am J Respir Crit Care Med. 2010;181(6):566-577.
121. Stalmeier PF. Adherence and decision AIDs: a model and a narrative review. Med Decis Making. 2011;31(1):121-129.
122. Oates DJ, Paasche-Orlow MK. Health literacy: communication strategies to improve patient comprehension of cardiovascular health. Circulation. 2009;119(7):1049-1051.
123. Hahn SR. Patient-centered communication to assess and enhance patient adherence to glaucoma medication. Ophthalmology. 2009;116(Suppl 11):S37-S42.
124. Gabbay RA, Durdock K. Strategies to increase adherence through diabetes technology. J Diabetes Sci Technol. 2010;4(3):661-665.
125. Hahn SR, Lipton RB, Sheftell FD, et al. Healthcare provider-patient communication and migraine assessment: results of the American Migraine Communication Study, phase II. Curr Med Res Opin. 2008;24(6):1711-1718.
126. Morgan M. The significance of ethnicity for health promotion: patients use of antihypertensive drugs in inner London. Int J Epidemiol. 1995;24 Suppl 1:S79-S84.
127. Bissell P, Ward PR, Noyce PR. The dependent consumer: reflections on accounts of the risks of non-prescription medicines. Health (London). 2001;5(1):5-30.
128. Lynch N, Berry D. Differences in perceived risks and benefits of herbal, over-the-counter conventional, and prescribed conventional, medicines, and the implications of this for the safe and effective use of herbal products. Complement Ther Med. 2007;15(2):84-91.
129. Jarman CN, Perron BE, Kilbourne AM, Teh CF. Perceived treatment effectiveness, medication compliance, and complementary and alternative medicine use among veterans with bipolar disorder. J Altern Complement Med. 2010;16(3):251-255.
130. Owen-Smith A, Diclemente R, Wingood G. Complementary and alternative medicine use decreases adherence to HAART in HIV-positive women. AIDS Care. 2007;19(5):589-593.
131. Gohar F, Greenfield SM, Beevers DG, Lip GY, Jolly K. Self-care and adherence to medication: a survey in the hypertension outpatient clinic. BMC Complement Altern Med. 2008;8:4.
132. Krousel-Wood MA, Muntner P, Joyce CJ, et al. Adverse effects of complementary and alternative medicine on antihypertensive medication adherence: findings from the cohort study of medication adherence among older adults. J Am Geriatr Soc. 2010;58(1):54-61.
133. Roy A, Lurslurchachai L, Halm EA, Li XM, Leventhal H, Wisnivesky JP. Use of herbal remedies and adherence to inhaled corticosteroids among inner-city asthmatic patients. Ann Allergy Asthma Immunol. 2010;104(2):132-138.
134. Dean AJ, Wragg J, Draper J, McDermott BM. Predictors of medication adherence in children receiving psychotropic medication. J Paediatr Child Health. 2011;47(6):350-355.
135. Villagran M, Hajek C, Zhao X, Peterson E, Wittenberg-Lyles E. Communication and culture: predictors of treatment adherence among Mexican immigrant patients. J Health Psychol. 2012;17(3):443-452.
136. Brown CM, Pena A, Resendiz K. Pharmacists' actions when patients use complementary and alternative medicine with medications: a look at Texas-Mexico border cities. J Am Pharm Assoc (2003). 2011;51(5):619-622.
137. Chong CA, Diaz-Granados N, Hawker GA, Jamal S, Josse RG, Cheung AM. Complementary and alternative medicine use by osteoporosis clinic patients. Osteoporos Int. 2007;18(11):1547-1556.
138. Mak JC, Faux S. Use of complementary and alternative medicine by patients with osteoporosis in Australia. Med J Aust. 2010;192(1):54-55.
139. Leung TN, Haines CJ, Chung TK. Five-year compliance with hormone replacement therapy in postmenopausal Chinese women in Hong Kong. Maturitas. 2001;39(3):195-201.
140. Son H, Park K, Kim SW, Paick JS. Reasons for discontinuation of sildenafil citrate after successful restoration of erectile function. Asian J Androl. 2004;6(2):117-120.
141. Brown KK, Rehmus WE, Kimball AB. Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis. J Am Acad Dermatol. 2006;55(4):607-613.
142. Ulrik CS, Backer V, Søes-Petersen U, Lange P, Harving H, Plaschke PP. The patient's perspective: adherence or non-adherence to asthma controller therapy? J Asthma. 2006;43(9):701-704.
143. van Geffen EC, van Hulten R, Bouvy ML, Egberts AC, Heerdink ER. Characteristics and reasons associated with nonacceptance of selective serotonin-reuptake inhibitor treatment. Ann Pharmacother. 2008;42(2):218-225.
144. Harrison T. Primary non-adherence to statin therapy in an integrated delivery system: patients' perspective. Clin Med Res. 2011;9(3-4):150-151.
145. Lakatos PL, Czegledi Z, David G, et al. Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease. J Crohns Colitis. 2010;4(3):283-290.
146. Buston KM, Wood SF. Non-compliance amongst adolescents with asthma: listening to what they tell us about self-management. Fam Pract. 2000;17(2):134-138.
147. Morris LA. A survey of patients' receipt of prescription drug information. Med Care. 1982;20(6):596-605.
148. Gallup G Jr, Cotugno HE. Preferences and practices of Americans and their physicians in antihypertensive therapy. Am J Med. 1986;81(6C):20-24.
149. Davis K, Schoen C, Schoenbaum SC, et al. Mirror, Mirror on the Wall: An Update on the Quality of American Health Care Through the Patient's Lens. New York: The Commonwealth Fund;2006. Available from: http://www.commonwealthfund.org/Publications/Fund-Reports/2006/Apr/Mirror-Mirror-on-the-Wall-An-Update-on-the-Quality-of-American-Health-Care-Through-the-Patients-Le.aspx. Accessed September 14, 2012.
150. Faden RR, Becker C, Lewis C, Freeman J, Faden AI. Disclosure of information to patients in medical care. Med Care. 1981;19(7):718-733.
151. Stevenson FA. The strategies used by general practitioners when providing information about medicines. Patient Educ Couns. 2001;43(1):97-104.
152. Nair K, Dolovich L, Cassels A, et al. What patients want to know about their medications. Focus group study of patient and clinician perspectives. Can Fam Physician. 2002;48:104-110.
153. Xu F. Informing patients about drug effects using positive suggestion. J Manag Care Pharm. 2008;14(4):395-396.
154. Tarn DM, Paterniti DA, Williams BR, Cipri CS, Wenger NS. Which providers should communicate which critical information about a new medication? Patient, pharmacist, and physician perspectives. J Am Geriatr Soc. 2009;57(3):462-469.
155. Myers ED, Calvert EJ. The effect of forewarning on the occurrence of side-effects and discontinuance of medication in patients on amitriptyline. Br J Psychiatry. 1973;122(569):461-464.
156. Myers ED, Calvert EJ. The effect of forewarning on the occurrence of side-effects and discontinuance of medication in patients on dothiepin. J Int Med Res. 1976;4(4):237-240.
157. Myers ED, Calvert EJ. Information, compliance and side-effects: a study of patients on antidepressant medication. Br J Clin Pharmacol. 1984;17(1):21-25.
158. Gibbs S, Waters WE, George CF. Prescription information leaflets: a national survey. J R Soc Med. 1990;83(5):292-297.
159. Howland JS, Baker MG, Poe T. Does patient education cause side effects? A controlled trial. J Fam Pract. 1990;31(1):62-64.
160. Quaid KA, Faden RR, Vining EP, Freeman JM. Informed consent for a prescription drug: impact of disclosed information on patient understanding and medical outcomes. Patient Educ Couns. 1990;15(3):249-259.
161. Lamb GC, Green SS, Heron J. Can physicians warn patients of potential side effects without fear of causing those side effects? Arch Intern Med. 1994;154(23):2753-2756.
162. Baker D, Roberts DE, Newcombe RG, Fox KA. Evaluation of drug information for cardiology patients. Br J Clin Pharmacol. 1991;31(5)525-531.
163. Gandhi TK, Burstin HR, Cook EF, et al. Drug complications in outpatients. J Gen Intern Med. 2000;15(3):149-154.
164. Happell B, Manias E, Roper C. Wanting to be heard: mental health consumers' experiences of information about medication. Int J Ment Health Nurs. 2004;13(4):242-248.
165. Coulter A. Partnerships with patients: the pros and cons of shared clinical decision-making. J Health Serv Res Policy. 1997;2(2):112-121.
166. Thrasher AD, Earp JA, Golin CE, Zimmer CR. Discrimination, distrust, and racial/ethnic disparities in antiretroviral therapy adherence among a national sample of HIV-infected patients. J Acquir Immune Defic Syndr. 2008;49(1):84-93.
167. Kerse N, Buetow S, Mainous AG 3rd, Young G, Coster G, Arroll B. Physician-patient relationship and medication compliance: a primary care investigation. Ann Fam Med. 2004;2(5):455-461.
168. Schneider J, Kaplan SH, Greenfield S, Li W, Wilson IB. Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. J Gen Intern Med. 2004;19(11):1096-1103.
169. Piette JD, Heisler M, Krein S, Kerr EA. The role of patient-physician trust in moderating medication nonadherence due to cost pressures. Arch Intern Med. 2005;165(15):1749-1755.
170. McGinnis B, Olson KL, Magid D, et al. Factors related to adherence to statin therapy. Ann Pharmacother. 2007;41(11):1805-1811.
171. Nguyen GC, LaVeist TA, Harris ML, Datta LW, Bayless TM, Brant SR. Patient trust-in-physician and race are predictors of adherence to medical management in inflammatory bowel disease. Inflamm Bowel Dis. 2009;15(8):1233-1239.
172. Ren XS, Kazis LE, Lee A, Zhang H, Miller DR. Identifying patient and physician characteristics that affect compliance with antihypertensive medications. J Clin Pharm Ther. 2002;27(1):47-56.
173. Loh A, Leonhart R, Wills CE, Simon D, Harter M. The impact of patient participation on adherence and clinical outcome in primary care of depression. Patient Educ Couns. 2007;65(1):69-78.
174. Kahn KL, Schneider EC, Malin JL, Adams JL, Epstein AM. Patient centered experiences in breast cancer: predicting long-term adherence to tamoxifen use. Med Care. 2007;45(5):431-439.
175. Arbuthnott A, Sharpe D. The effect of physician-patient collaboration on patient adherence in non-psychiatric medicine. Patient Educ Couns. 2009;77(1):60-67.
176. Zolnierek KB, Dimatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Med Care. 2009;47(8):826-834.
177. Greenfield S, Kaplan S, Ware JE Jr. Expanding patient involvement in care: Effects on patient outcomes. Ann Intern Med. 1985;102(4):520-528.
178. Greenfield S, Kaplan SH, Ware JE Jr, Yano EM, Frank HJ. Patients' participation in medical care: effects on blood sugar control and quality of life in diabetes. J Gen Intern Med. 1988;3(5):448-457.
179. O'Connor AM, Rostom A, Fiset V, et al. Decision aids for patients facing health treatment or screening decisions: systematic review. BMJ. 1999;319(7212):731-734.
180. Butow P, Devine R, Boyer M, Pendlebury S, Jackson M, Tattersall MH. Cancer consultation preparation package: changing patients but not physicians is not enough. J Clin Oncol. 2004;22(21):4401-4409.
181. Griffin SJ, Kinmonth AL, Veltman MW, Gillard S, Grant J, Stewart M. Effect on health-related outcomes of interventions to alter the interaction between patients and practitioners: a systematic review of trials. Ann Fam Med. 2004;2(6):595-608.
182. Williams GC, McGregor H, Zeldman A, Freedman ZR, Deci EL, Elder D. Promoting glycemic control through diabetes self-management: evaluating a patient activation intervention. Patient Educ Couns. 2005;56(1):28-34.
183. Loh A, Simon D, Wills CE, Kriston L, Niebling W, Härter M. The effects of a shared decision-making intervention in primary care of depression: a cluster-randomized controlled trial. Patient Educ Couns. 2007;67(3):324-332.
184. Mullan RJ, Montori VM, Shah ND, et al. The diabetes mellitus medication choice decision aid: a randomized trial. Arch Intern Med. 2009;169(17):1560-1568.
185. Parchman ML, Zeber JE, Palmer RF. Participatory decision making, patient activation, medication adherence, and intermediate clinical outcomes in type 2 diabetes: a STARNet study. Ann Fam Med. 2010;8(5):410-417.
186. US Census Bureau. Income in the past 12 months 2006 [FactFinder]. Available from: http://factfinder.census.gov/servlet/STTable?_bm=y&-geo_id=01000US&-qr_name=ACS_2006_EST_G00_S1901&-ds_name=ACS_2006_EST_G00_&-redoLog=false. Accessed July 3, 2008.
187. US Census Bureau. Educational attainment 2006 [FactFinder]. Available from: http://factfinder.census.gov/servlet/STTable?_bm=y&-geo_id=01000US&-qr_name=ACS_2006_EST_G00_S1501&-ds_name=ACS_2006_EST_G00. Accessed July 3, 2008.
188. Grieco EM, Cassidy RC. Overview of race and hispanic origin 2000. US Census Bureau; 2001. Available from: http://www.census.gov/prod/2001pubs/c2kbr01-1.pdf. Accessed July 3, 2008.
189. Clifford S, Barber N, Horne R. Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: application of the Necessity-Concerns Framework. J Psychosom Res. 2008;64(1):41-46.
190. Eraker SA, Kirscht JP, Becker MH. Understanding and improving patient compliance. Ann Intern Med. 1984;100(2):258-268.